Table 1.
Examples of drugs commonly used in paediatric medicine for which the paediatric dose is not linearly correlated with body weight
Drug | Therapeutic indication | Adult dose | Paediatric dose |
---|---|---|---|
Chloramphenicol | Bacterial infection | 50 mg kg−1 day−1 | 50 mg kg−1 day−1 |
neonates: 25 mg kg−1 day−1 | |||
Carbamazepine | Epilepsy | 5–8 mg kg−1 every 12 h | >12 years: 5–8 mg kg−1 every 12 h |
Children: 3–10 mg kg−1 every 8 h | |||
Infants: 3–10 mg kg−1 every 8 h | |||
Phenytoin | Epilepsy | 2 mg kg−1 every 12 h | Children: 2.3–2.6 mg−1 kg every 8 h |
Infants: 2.3 mg kg−1 every 8 h | |||
Neonates: 2.5–4.0 mg kg−1 every 12 h | |||
Propofol | Anaesthesia | <55 years: 6–12 mg kg−1 h−1 | 2 months–16 years: 7.5–18 mg kg−1 h−1 |
>55 years: 3–6 mg kg−1 h−1 | |||
Busulfan | Cancer | 0.8 mg kg−1 every 6 h | ≤12 kg: 1.1 mg kg−1 every 6 h |
>12 kg: 0.8 mg kg−1 every 6 h | |||
Tobramycin | Bacterial infection | 3 mg kg−1 day−1 | Children: 6–7.5 mg kg−1 day−1 |
<2 weeks: 4 mg kg−1 day−1 | |||
With cystic fibrosis: 10 mg kg−1 day−1 | |||
Enfuvirtide | HIV | 180 mg day−1 | 11–15.5 kg: 54 mg day−1 |
15.6–20 kg: 72 mg day−1 | |||
20.1–24.5 kg: 90 mg day−1 | |||
24.6–29 kg: 108 mg day−1 | |||
29.1–33.5 kg: 126 mg day−1 | |||
33.6–38 kg: 144 mg day−1 | |||
38.1–42.5 kg: 162 mg day−1 | |||
Oseltamivir | Influenza | 150 mg day−1 | <15 kg: 60 mg day−1 |
15–23 kg: 90 mg day−1 | |||
23–40 kg: 120 mg day−1 | |||
Nelfinavir | HIV | 2.5 g day−1 | 7.5–8.5 kg: 0.8 g day−1 |
8.5–10.5 kg: 1 g day−1 | |||
10.5–12 kg: 1.2 g day−1 | |||
12–14 kg: 1.4 g day−1 | |||
14–16 kg: 1.6 g day−1 | |||
16–18 kg: 1.8 g day−1 | |||
18–22 kg: 2.1 g day−1 | |||
Digoxin | Heart failure | 1.4–4.0 µg kg−1 day−1 | Children: 3–8 µg kg−1 day−1 |
Infants: 7.5–12 µg kg−1 day−1 | |||
Neonates: 4–8 µg kg−1 day−1 |
References for each drug are provided in the text together with further details about the clinical implication of nonlinearity between drug exposure and descriptors of body size.